[RhCl(CO)(1,3,5-triaza-7-phosphaadamantane)2] | 162072-57-3

• 英文名称: [RhCl(CO)(1,3,5-triaza-7-phosphaadamantane)2]
• 英文别名: [RhCl(CO)(PTA)2]
• CAS: 162072-57-3
• 化学式: C₁₃H₂₄ClN₆OP₂Rh
• 分子量: 480.679
• InChiKey: VAELZYCEWRTBKF-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  None
• 重原子数：
  None
• 可旋转键数：
  None
• 环数：
  None
• sp3杂化的碳原子比例：
  None
• 拓扑面积：
  None
• 氢给体数：
  None
• 氢受体数：
  None

反应信息

• 作为反应物：
  描述：

  N-氯代丁二酰亚胺 、 [RhCl(CO)(1,3,5-triaza-7-phosphaadamantane)2] 、 水 以 水 为溶剂， 以80%的产率得到[RhCl2(1,3,5-triaza-7-phosphaadamantane)(1,3,5-triaza-7-phosphaadamantane(+H))]*H2O
  参考文献：
  名称：

  Transformations of the Vaska-type complex trans-[RhCl(CO)(PTA)2] (PTA=1,3,5-triaza-7-phosphaadamantane) during stepwise addition of HCl: Synthesis, characterization and crystal structure of trans-[RhCl2(PTA)(PTAH)]

  摘要：

  The new aqua-soluble rhodium(I) complex trans-[RhCl2(PTA)(PTAH)] (1) {PTAH = N-protonated form of 1,3,5-triaza-7-phosphaadamantane (PTA)} has been synthesized via the reaction of trans[ RhCl(CO)(PTA)(2)] with aqueous HCl or N-chlorosuccinimide, or by the treatment of RhCl3 with PTA. Compound 1 has been characterized by IR, H-1 and P-31{H} NMR spectroscopies, ESI-MS(+), elemental and single crystal X-ray diffraction analyses, the latter showing a square planar {RhCl2P2} geometry. Besides, the stepwise addition of diluted HCl to an aqueous solution of trans-[RhCl(CO)(PTA)(2)] has been monitored by P-31{H-1} NMR and ESI-MS(+) techniques, allowing to detect a number of intermediate Rh(I) species. (C) 2011 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.ica.2011.09.002